Osteonecrosis due to drugs, left toe(s)
ICD-10 M87.178 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, left toe(s).
Osteonecrosis due to drugs, specifically affecting the left toe(s), is a condition characterized by the death of bone tissue due to a lack of blood supply, which can be precipitated by certain medications. This condition often arises from the use of corticosteroids, bisphosphonates, or other drugs that can compromise blood flow to the bones. Patients may present with localized pain, swelling, and limited mobility in the affected toe(s). The diagnosis is typically confirmed through imaging studies such as MRI or X-rays, which can reveal changes in bone density and structure. Osteonecrosis can lead to severe complications, including the risk of fractures and the need for surgical interventions such as joint replacement. It is crucial for healthcare providers to monitor patients on long-term medication regimens for signs of osteonecrosis, especially in high-risk populations, to ensure timely intervention and management.
Detailed patient history, imaging results, and treatment plans.
Patients presenting with pain in the toe(s) after starting corticosteroid therapy.
Orthopedic surgeons must document the extent of bone involvement and any surgical interventions planned.
Comprehensive medication history and assessment of joint involvement.
Patients with autoimmune conditions on long-term immunosuppressive therapy presenting with toe pain.
Rheumatologists should monitor for signs of osteonecrosis in patients receiving high-dose corticosteroids.
Used when a patient with osteonecrosis requires joint aspiration for pain relief.
Document the reason for aspiration and the findings.
Orthopedic specialists should ensure proper coding for joint procedures related to osteonecrosis.
Common medications include corticosteroids, bisphosphonates, and certain chemotherapeutic agents. It is important to document any relevant medication history when coding.
